YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer-Reference-Cited by-同舟云学术

YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer

Published:2023-06 Issue: Volume:563 Page:216184
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Ziyi,Wang Shijia,Jia Ziheng,Hu Yunping,Cao Dongyan,Yang Mingjie,Liu Liguo,Gao Li,Qiu Shimei,Yan Weikang,Li Yiming,Luo Jing,Geng Yajun,Zhang Jingyun,Li Zhizhen,Wang Xuan,Li Maolan,Shao Rong,Liu Yingbin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Gallbladder cancer: epidemiology and genetic risk associations;Schmidt;Chin. Clin. Oncol.,2019

2. Epidemiological characteristics, diagnosis, treatment and prognosis of gallbladder cancer in China: a report of 6 159 cases;Sun;Chin J Dig Surg,2022

3. Current standards and future perspectives in adjuvant treatment for biliary tract cancers;Lamarca;Cancer Treat Rev.,2020

4. Gallbladder cancer;Roa;Nat. Rev. Dis. Prim.,2022

5. Long-term exposure to genistein inhibits the proliferation of gallbladder cancer by downregulating the MCM complex;Geng;Sci. Bull.,2022

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer;Molecular Cancer;2024-09-13

2. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

3. Regulation and Crosstalk of Cells and Factors in the Pancreatic Cancer Microenvironment;Current Cancer Drug Targets;2024-09-02

4. The emerging role of CHI3L1 as a diagnostic marker and therapeutic target in allergic diseases and respiratory comorbidities;Allergy Medicine;2024-09

5. Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers;Cancer Cell International;2024-07-27